Endemic Mycoses: What’s New About Old Diseases?
暂无分享,去创建一个
[1] J. Perfect,et al. Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] A. Flisser,et al. Update of phylogenetic and genetic diversity of Sporothrix schenckii sensu lato. , 2016, Medical mycology.
[3] S. Rudramurthy,et al. Disseminated Emmonsia pasteuriana infection in India: a case report and a review , 2016, Mycoses.
[4] L. Xi,et al. Whole blood Nested PCR and Real-time PCR amplification of Talaromyces marneffei specific DNA for diagnosis. , 2016, Medical mycology.
[5] A. Batista-Duharte,et al. A cell wall protein-based vaccine candidate induce protective immune response against Sporothrix schenckii infection. , 2016, Immunobiology.
[6] Crystal M. Hepp,et al. Local Population Structure and Patterns of Western Hemisphere Dispersal for Coccidioides spp., the Fungal Cause of Valley Fever , 2015, mBio.
[7] Disseminated histoplasmosis in Central and South America, the invisible elephant: the lethal blind spot of international health organizations. , 2016, AIDS.
[8] B. Gern,et al. Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice. , 2016, The Journal of clinical investigation.
[9] Benquan Wu,et al. Disseminated infection caused by Emmonsia pasteuriana in a renal transplant recipient , 2015, The Journal of dermatology.
[10] A. Ralph,et al. Epidemiological investigation of an outbreak of cutaneous sporotrichosis, Northern Territory, Australia , 2015, BMC Infectious Diseases.
[11] A. M. Rodrigues,et al. Molecular Diagnosis of Pathogenic Sporothrix Species , 2015, PLoS neglected tropical diseases.
[12] Chen Zhang,et al. Evaluation of two new enzyme immunoassay reagents for diagnosis of histoplasmosis in a cohort of clinically characterized patients. , 2015, Medical mycology.
[13] M. Xavier,et al. Sporothrix brasiliensis outbreaks and the rapid emergence of feline sporotrichosis , 2015, Mycoses.
[14] Hui Zhou,et al. Cutaneous Disseminated Emmonsiosis Due to Emmonsia pasteuriana in a Patient With Cytomegalovirus Enteritis. , 2015, JAMA dermatology.
[15] Christina A. Cuomo,et al. 50 Years of Emmonsia Disease in Humans: The Dramatic Emergence of a Cluster of Novel Fungal Pathogens , 2015, PLoS pathogens.
[16] T. Chiller,et al. Mycotic Infections Acquired outside Areas of Known Endemicity, United States , 2015, Emerging infectious diseases.
[17] L. Wheat,et al. Histoplasmosis: Up-to-Date Evidence-Based Approach to Diagnosis and Management , 2015, Seminars in Respiratory and Critical Care Medicine.
[18] Juno Thomas,et al. An Outbreak of Lymphocutaneous Sporotrichosis among Mine-Workers in South Africa , 2015, PLoS neglected tropical diseases.
[19] R. Martinez. EPIDEMIOLOGY OF PARACOCCIDIOIDOMYCOSIS , 2015, Revista do Instituto de Medicina Tropical de Sao Paulo.
[20] M. Money,et al. Histoplasmosis complicating tumor necrosis factor-α blocker therapy: a retrospective analysis of 98 cases. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] L. Wheat,et al. Role of Coccidioides Antigen Testing in the Cerebrospinal Fluid for the Diagnosis of Coccidioidal Meningitis. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] C. Hung,et al. Evaluation of the matrix-assisted laser desorption/ionization time-of-flight mass spectrometry Bruker Biotyper for identification of Penicillium marneffei, Paecilomyces species, Fusarium solani, Rhizopus species, and Pseudallescheria boydii , 2015, Frontiers in Microbiology.
[23] M. Mendelson,et al. Clinical Characteristics, Diagnosis, Management, and Outcomes of Disseminated Emmonsiosis: A Retrospective Case Series. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[24] N. Ampel,et al. The Return of Delayed-Type Hypersensitivity Skin Testing for Coccidioidomycosis. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[25] S. Seyedmousavi,et al. Neglected fungal zoonoses: hidden threats to man and animals. , 2015, Clinical Microbiology and Infection.
[26] G. Sarosi,et al. Histoplasmosis Infections Worldwide: Thinking Outside of the Ohio River Valley , 2015, Current Tropical Medicine Reports.
[27] Anand Kumar,et al. Extracorporeal membrane oxygenation for blastomycosis-related acute respiratory distress syndrome: a case series , 2015, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.
[28] W. de Souza,et al. Miltefosine is active against Sporothrix brasiliensis isolates with in vitro low susceptibility to amphotericin B or itraconazole. , 2015, Journal of medical microbiology.
[29] S. R. de Almeida,et al. Immunoproteomic analysis reveals a convergent humoral response signature in the Sporothrix schenckii complex. , 2015, Journal of proteomics.
[30] N. Lima,et al. Development and optimization of a new MALDI-TOF protocol for identification of the Sporothrix species complex. , 2015, Research in microbiology.
[31] Y. Zhang,et al. Phylogeography and evolutionary patterns in Sporothrix spanning more than 14 000 human and animal case reports , 2015, Persoonia.
[32] M. Loeffelholz,et al. Symptomatic and Asymptomatic Respiratory Viral Infections in the First Year of Life: Association With Acute Otitis Media Development , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[33] D. Engelthaler,et al. Valley fever: finding new places for an old disease: Coccidioides immitis found in Washington State soil associated with recent human infection. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[34] A. Chakrabarti,et al. Global epidemiology of sporotrichosis. , 2015, Medical mycology.
[35] G. Rutherford,et al. Call for a California Coccidioidomycosis Consortium to Face the Top Ten Challenges Posed by a Recalcitrant Regional Disease , 2014, Mycopathologia.
[36] M. Strobel,et al. Penicilliosis and AIDS in Haiphong, Vietnam: evolution and predictive factors of death. , 2014, Medecine et maladies infectieuses.
[37] S. Antinori. Histoplasma capsulatum: More Widespread than Previously Thought , 2014, The American journal of tropical medicine and hygiene.
[38] C. Cabellos,et al. A second look at Emmonsia infection can make the difference , 2014, Transplant infectious disease : an official journal of the Transplantation Society.
[39] E. Anaissie,et al. Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant‐Associated Infection Surveillance Network (TRANSNET) , 2014, Transplant infectious disease : an official journal of the Transplantation Society.
[40] N. Govender,et al. An emmonsia species causing disseminated infection in South Africa. , 2014, The New England journal of medicine.
[41] A. M. Rodrigues,et al. Emerging sporotrichosis is driven by clonal and recombinant Sporothrix species , 2014, Emerging Microbes & Infections.
[42] J. Baddley,et al. Histoplasmosis in Patients With Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) , 2014, Medicine.
[43] D. Salmon,et al. First observation in a non-endemic country (Togo) of Penicillium marneffei infection in a human immunodeficiency virus-infected patient: a case report , 2013, BMC Research Notes.
[44] Yitian Zhou,et al. Development of a Loop-Mediated Isothermal Amplification Method for Detection of Histoplasma capsulatum DNA in Clinical Samples , 2013, Journal of Clinical Microbiology.
[45] D. Leland,et al. Development of a Highly Sensitive and Specific Blastomycosis Antibody Enzyme Immunoassay Using Blastomyces dermatitidis Surface Protein BAD-1 , 2013, Clinical and Vaccine Immunology.
[46] Mathieu Nacher,et al. Disseminated Histoplasmosis in HIV-Infected Patients in South America: A Neglected Killer Continues on Its Rampage , 2013, PLoS neglected tropical diseases.
[47] M. Mendelson,et al. A dimorphic fungus causing disseminated infection in South Africa. , 2013, The New England journal of medicine.
[48] T. Daly,et al. Evaluation of Commercially Available Reagents for Diagnosis of Histoplasmosis Infection in Immunocompromised Patients , 2013, Journal of Clinical Microbiology.
[49] George R Thompson,et al. Coccidioidomycosis: epidemiology , 2013, Clinical epidemiology.
[50] T. Kasuga,et al. Multilocus sequence typing of Histoplasma capsulatum in formalin-fixed paraffin-embedded tissues from cats living in non-endemic regions reveals a new phylogenetic clade. , 2013, Medical mycology.
[51] D. Low,et al. Phylogenetic Analysis Reveals a Cryptic Species Blastomyces gilchristii, sp. nov. within the Human Pathogenic Fungus Blastomyces dermatitidis , 2013, PloS one.
[52] A. Limaye,et al. Coccidioidomycosis acquired in Washington State. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[53] D. Engelthaler,et al. Coccidioidomycosis: adenosine deaminase levels, serologic parameters, culture results, and polymerase chain reaction testing in pleural fluid. , 2013, Chest.
[54] S. Hinrichs,et al. Applying a Real-Time PCR Assay for Histoplasma capsulatum to Clinically Relevant Formalin-Fixed Paraffin-Embedded Human Tissue , 2012, Journal of Clinical Microbiology.
[55] Suzanne M Johnson,et al. Serum (1→3)-β-d-Glucan Measurement in Coccidioidomycosis , 2012, Journal of Clinical Microbiology.
[56] M. Felipe,et al. Genus Paracoccidioides: Species Recognition and Biogeographic Aspects , 2012, PloS one.
[57] N. Wengenack,et al. Erratum: A multicenter evaluation of tests for diagnosis of histoplasmosis (Clinical Infectious Diseases (2011) 53 (448-454)) , 2012 .
[58] J. Graybill,et al. Adiaspiromycosis Causing Respiratory Failure and a Review of Human Infections Due to Emmonsia and Chrysosporium spp , 2012, Journal of Clinical Microbiology.
[59] L. Wheat,et al. Blastomyces dermatitidis Antigen Detection by Quantitative Enzyme Immunoassay , 2011, Clinical and Vaccine Immunology.
[60] J. Frisvad,et al. Phylogeny and nomenclature of the genus Talaromyces and taxa accommodated in Penicillium subgenus Biverticillium , 2011, Studies in mycology.
[61] C. Rappleye,et al. Histoplasma mechanisms of pathogenesis--one portfolio doesn't fit all. , 2011, FEMS microbiology letters.
[62] N. E. Babady,et al. A multicenter evaluation of tests for diagnosis of histoplasmosis. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[63] M. Fisher,et al. Population Genetic Structure of Clinical and Environmental Isolates of Blastomyces dermatitidis, Based on 27 Polymorphic Microsatellite Markers , 2011, Applied and Environmental Microbiology.
[64] C. Zaitz,et al. Cutaneous sporotrichosis treatment with potassium iodide: a 24 year experience in São Paulo State, Brazil. , 2011, Revista do Instituto de Medicina Tropical de Sao Paulo.
[65] T. Krajaejun,et al. Safety, Tolerability, and Immunogenicity of a Recombinant, Genetically Engineered, Live-Attenuated Vaccine against Canine Blastomycosis , 2011, Clinical and Vaccine Immunology.
[66] M. Hanf,et al. What is AIDS in the Amazon and the Guianas? Establishing the burden of disseminated histoplasmosis. , 2011, The American journal of tropical medicine and hygiene.
[67] B. Gern,et al. Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice. , 2011, The Journal of clinical investigation.
[68] N. Ampel,et al. An official American Thoracic Society statement: Treatment of fungal infections in adult pulmonary and critical care patients. , 2011, American journal of respiratory and critical care medicine.
[69] Benjamin J Park,et al. Enhanced Surveillance of Coccidioidomycosis, Arizona, USA, 2007–2008 , 2010, Emerging infectious diseases.
[70] F. Lamontagne,et al. Corticosteroids as adjunctive therapy in severe blastomycosis-induced acute respiratory distress syndrome in an immunosuppressed patient. , 2010, Clinical Infectious Diseases.
[71] J. Parsonnet,et al. Final report of the Lyme disease review panel of the Infectious Diseases Society of America. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[72] Patty W. Wright,et al. Blastomycosis of the central nervous system: a multicenter review of diagnosis and treatment in the modern era. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[73] C. Aznar,et al. Detection of Histoplasma capsulatum DNA in human samples by real-time polymerase chain reaction. , 2010, Diagnostic microbiology and infectious disease.
[74] M. Brandt,et al. Diagnosis of acute pulmonary histoplasmosis by antigen detection. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[75] P. D. Rogers,et al. The Role of Voriconazole in the Treatment of Central Nervous System Blastomycosis , 2009, The Annals of pharmacotherapy.
[76] L. Mendoza,et al. Phylogenetic analysis reveals a high level of speciation in the Paracoccidioides genus. , 2009, Molecular phylogenetics and evolution.
[77] S. Peterson,et al. P208 Molecular genetic analysis supports recognition of new species among Emmonsia and Blastomyces isolates , 2009 .
[78] T. Chiller,et al. Development and Evaluation of an Enzyme-Linked Immunosorbent Assay To Detect Histoplasma capsulatum Antigenuria in Immunocompromised Patients , 2009, Clinical and Vaccine Immunology.
[79] M. Threlkeld,et al. Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[80] Michael D. Ober,et al. Corticosteroids for blastomycosis-induced ARDS: a report of two patients and review of the literature. , 2008, Chest.
[81] F. Queiroz-Telles,et al. An open-label comparative pilot study of oral voriconazole and itraconazole for long-term treatment of paracoccidioidomycosis. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[82] J. Guarro,et al. In Vitro Antifungal Susceptibilities of Five Species of Sporothrix , 2007, Antimicrobial Agents and Chemotherapy.
[83] P. Pappas,et al. Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[84] L. Wheat,et al. Detection of Histoplasma Antigen by a Quantitative Enzyme Immunoassay , 2007, Clinical and Vaccine Immunology.
[85] J. Baddley,et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[86] Hsin-Yun Sun,et al. Detection of Circulating Galactomannan in Serum Samples for Diagnosis of Penicillium marneffei Infection and Cryptococcosis among Patients Infected with Human Immunodeficiency Virus , 2007, Journal of Clinical Microbiology.
[87] G. Deepe,et al. Advances in combating fungal diseases: vaccines on the threshold , 2007, Nature Reviews Microbiology.
[88] C. Kauffman. Endemic mycoses: blastomycosis, histoplasmosis, and sporotrichosis. , 2006, Infectious disease clinics of North America.
[89] N. Ampel,et al. Coccidioidomycosis as a Common Cause of Community-acquired Pneumonia , 2006, Emerging infectious diseases.
[90] T. Sirisanthana,et al. Penicillium marneffei Infection and Recent Advances in the Epidemiology and Molecular Biology Aspects , 2006, Clinical Microbiology Reviews.
[91] John W. Taylor,et al. Cryptic speciation and recombination in the fungus Paracoccidioides brasiliensis as revealed by gene genealogies. , 2006, Molecular biology and evolution.
[92] S. Emady-Azar,et al. Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day−1) in the treatment of cutaneous or lymphocutaneous sporotrichosis , 2004, Mycoses.
[93] T. White,et al. Phylogeography of the fungal pathogen Histoplasma capsulatum , 2003, Molecular ecology.
[94] F. Queiroz-Telles,et al. Detection of Circulating gp43 Antigen in Serum, Cerebrospinal Fluid, and Bronchoalveolar Lavage Fluid of Patients with Paracoccidioidomycosis , 2003, Journal of Clinical Microbiology.
[95] Y. Srinoulprasert,et al. Antigen Detection Assay for Identification of Penicillium marneffei Infection , 2003, Journal of Clinical Microbiology.
[96] E. Hershfield,et al. Epidemiology and clinical spectrum of blastomycosis diagnosed at Manitoba hospitals. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[97] John W. Taylor,et al. Phylogenetic Analysis of Lacazia loboiPlaces This Previously Uncharacterized Pathogen within the Dimorphic Onygenales , 2001, Journal of Clinical Microbiology.
[98] K. Tintelnot,et al. Disseminated Penicillium marneffei infection in an African AIDS patient. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[99] E. Guého,et al. Cutaneous disseminated mycosis in a patient with AIDS due to a new dimorphic fungus , 2008 .
[100] R. Hay,et al. Antigenemia in Patients with Paracoccidioidomycosis: Detection of the 87-Kilodalton Determinant during and after Antifungal Therapy , 1998, Journal of Clinical Microbiology.
[101] K. Nelson,et al. Amphotericin B and itraconazole for treatment of disseminated Penicillium marneffei infection in human immunodeficiency virus-infected patients. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[102] Blastomycosis--Wisconsin, 1986-1995. , 1996, MMWR. Morbidity and mortality weekly report.